Jacobs Bruce N.
Chief Financial Officer · 21 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | KYMR | Kymera Therapeutics, Inc. | Sale | 51,375 | $114.77 | $5.9M | filing |
| 2026-06-30 | KYMR | Kymera Therapeutics, Inc. | Sale | 7,971 | $115.82 | $923,178.10 | filing |
| 2026-06-30 | KYMR | Kymera Therapeutics, Inc. | Sale | 6,153 | $116.99 | $719,862.24 | filing |
| 2026-06-30 | KYMR | Kymera Therapeutics, Inc. | Sale | 4,110 | $114.19 | $469,310.63 | filing |
| 2026-06-30 | KYMR | Kymera Therapeutics, Inc. | Sale | 3,200 | $117.70 | $376,649.28 | filing |
| 2026-06-30 | KYMR | Kymera Therapeutics, Inc. | Option exercise | 61,378 | $5.33 | $327,144.74 | filing |
| 2026-06-30 | KYMR | Kymera Therapeutics, Inc. | Sale | 1,700 | $111.57 | $189,664.07 | filing |
| 2026-06-30 | KYMR | Kymera Therapeutics, Inc. | Sale | 1,500 | $110.54 | $165,809.55 | filing |
| 2026-06-30 | KYMR | Kymera Therapeutics, Inc. | Sale | 1,100 | $112.79 | $124,066.91 | filing |
| 2026-06-02 | KYMR | Kymera Therapeutics, Inc. | Option exercise | 12,653 | $2.08 | $26,318.24 | filing |
| 2026-05-18 | KYMR | Kymera Therapeutics, Inc. | Option exercise | 15,000 | $2.08 | $31,200.00 | filing |
| 2026-03-04 | KYMR | Kymera Therapeutics, Inc. | Sale | 2,519 | $85.04 | $214,206.69 | filing |
| 2026-03-04 | KYMR | Kymera Therapeutics, Inc. | Sale | 1,437 | $85.78 | $123,266.87 | filing |
| 2026-03-04 | KYMR | Kymera Therapeutics, Inc. | Sale | 492 | $84.00 | $41,326.28 | filing |
| 2026-03-04 | KYMR | Kymera Therapeutics, Inc. | Sale | 447 | $86.62 | $38,721.24 | filing |
| 2026-03-02 | KYMR | Kymera Therapeutics, Inc. | Sale | 4,113 | $89.66 | $368,760.89 | filing |
| 2026-03-02 | KYMR | Kymera Therapeutics, Inc. | Sale | 2,039 | $87.75 | $178,924.09 | filing |
| 2026-03-02 | KYMR | Kymera Therapeutics, Inc. | Sale | 1,424 | $88.50 | $126,024.57 | filing |
| 2026-03-02 | KYMR | Kymera Therapeutics, Inc. | Award | 17,650 | $0.00 | $0.00 | filing |
| 2025-09-17 | KYMR | Kymera Therapeutics, Inc. | Sale | 79,220 | $50.00 | $4.0M | filing |
| 2025-09-17 | KYMR | Kymera Therapeutics, Inc. | Option exercise | 79,220 | $2.08 | $164,777.60 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.